PD-1/PD-L1 checkpoint inhibitor (AbbVie)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePD-1/PD-L1 checkpoint inhibitor (AbbVie)
Drug Alias Nameprogrammed cell death-1/programmed death-ligand 1 checkpoint inhibitor (AbbVie)resorcinol dibenzyl ether derivatives (AbbVie)dual PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (AbbVie)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 blockersProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A